A total of 25.9% (34,398) of participants started treatment with CD4 counts less than 200 cells/mm3, and 5.8% (7,747 individuals) had at least one episode of active tuberculosis and 1.9% (2,515) died of HIV disease during the study period (Table 1). Here, CD4 is linked to tuberculosis.